Arm competitive analysis

Latest publications and patents of Arm New

Explore the latest publications and patents granted to Arm, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Arm

Sep 3, 2025Apparatus And MethodGranted And Under Opposition
Jul 30, 2025Methods Of Using Interleukin-10 For Treating Diseases And DisordersGranted And Under Opposition
Nov 24, 2021Scratch Resistant Coating Composition With A Combination Of Hard ParticlesPatent Maintained As Amended
Nov 3, 2021Scratch Resistant CoatingPatent Maintained As Amended
Aug 11, 2021Highly Fire-Resistant Expanded Polymeric MaterialGranted And Under Opposition
Jun 16, 2021Flexible Foam With Improved Insulation PropertiesRevoked
Nov 20, 2019Expansion System For Flexible Insulation FoamsRevoked
Aug 14, 2019Acoustic Ceiling Board With Improved AestheticsOpposition Rejected
May 15, 2019Grouped Tooth Electric MotorIntended To Grant
May 16, 2018Durable Uv Curable CoatingsRevoked

Explore patent oppositions filed by Arm against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

High Dose And Low Volume Botulinum Toxin Treatment Of Facial WrinklesMERZ PHARMAAug 20, 2025
Preparation Containing Tetracyclic Compound At High DoseCHUGAI SEIYAKU KABUSHIKI KAISHAAug 19, 2025
Assay For Jc Virus AntibodiesBIOGEN MAAug 19, 2025
Use Of Migalostat In Reducing The Risk Of Cerebrovascular Event In Patients With Fabry DiseaseAMICUS THERAPEUTICSAug 13, 2025
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 22, 2025
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 21, 2025
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 16, 2025
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICSJul 9, 2025
Anticancer CompositionsARAGON PHARMACEUTICALSJul 8, 2025

Explore Arm's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 24, 2021Scratch Resistant Coating Composition With A Combination Of Hard Particles1
Nov 3, 2021Scratch Resistant Coating1
Aug 11, 2021Highly Fire-Resistant Expanded Polymeric Material1
Jun 16, 2021Flexible Foam With Improved Insulation Properties1
Nov 20, 2019Expansion System For Flexible Insulation Foams1
Aug 14, 2019Acoustic Ceiling Board With Improved Aesthetics1
May 16, 2018Durable Uv Curable Coatings1
May 3, 2017Cleaning Installation For Industrially Manufactured Components1

Latest PTAB cases involving Arm

Discover the latest PTAB cases involving Arm, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Arm

IPR2025-00207Dec 13, 2024ARMDAEDALUS PRIMETrial Instituted
IPR2024-00851Apr 25, 2024RJ MACHINEARMATURENFABRIK FRANZ SCHNEIDERInstitution Denied
IPR2024-00566Feb 21, 2024ARMICPILLARTerminated-Settled
IPR2024-00476Jan 26, 2024ARMICPILLARTerminated-Settled
IPR2021-00429Jan 25, 2021ARMLIBERTY PATENTSTerminated-Settled
IPR2019-00711Feb 21, 2019ARMASPECJ & K ASSETSTerminated-Settled
IPR2019-00058Oct 12, 2018ARMCOMPLEX MEMORYTerminated-Settled
IPR2019-00053Oct 12, 2018ARMCOMPLEX MEMORYTerminated
IPR2018-01149May 25, 2018ARMATI ULCFinal Written Decision
IPR2018-01148May 25, 2018ARMATI ULCFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Arm with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
UCB PHARMA - 12 - 8Non-Active
ALEMBIC PHARMACEUTICALS - - 2 - Highly Aggressive
JAMES POOLE151 - - - Highly Aggressive
MYLAN PHARMACEUTICALS - - 94 - Highly Aggressive